Brexanolone for severe postpartum depression
Part of Mental health, Women’s health & pregnancy clinical trials.
This trial tests an investigational medicine to help mothers with severe depression that started late in pregnancy or shortly after childbirth. It aims to improve mood and overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 15 to 45.
- Your depression started during your second or third trimester, or within 4 weeks after giving birth.
- It has been less than 18 months since you gave birth.
- You have severe depression as measured by a standard depression scale.
- You do not have a history of bipolar disorder, schizophrenia, or schizoaffective disorder.
- You have not had seizures in the past 6 months, and you are not currently experiencing active psychosis or suicidal behavior related to this depressive episode.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, MI078, to see if it can help women with postpartum depression. You may qualify if you are between 18 and 45, have given birth within the last year, and are currently experiencing moderate to severe depression that started in late pregnancy or shortly after delivery.
This trial tests whether timed light therapy can improve postpartum depression symptoms. It focuses on new mothers within six months of giving birth who have elevated depression scores.
This trial tests a new type of talk therapy for women who have given birth and are experiencing depression. It aims to see if this treatment can help improve their mood and well-being.
This study looks at whether brain scans and electrical signals can predict who might get postpartum depression, and tests a non-invasive brain stimulation treatment called TMS to see if it helps. Participating may give you early support and access to a treatment that could reduce your risk of depression after childbirth.
This study tests whether a medication given as a nasal spray during labor can lower the chance of developing depression after childbirth. It may help women who are having a planned vaginal delivery with pain relief.
This trial tests a program based on positive psychology to help prevent or reduce postpartum depression. It is offered within the primary healthcare system and focuses on supporting mothers early in pregnancy.
Hear when a new Postpartum Depression (PPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.